Fortitude Family Office’s AngioDynamics ANGO Stock Holding History

Fortitude Family Office’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.8K	Buy	+312	New	+$4.65K	﹤0.01%	1587

Other funds holding ANGO

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

MNBTD

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Fortitude Family Office's ANGO Position: Q3 2026 in Review

Fortitude Family Office opened a new position in AngioDynamics (ANGO) in Q3 2026: 312 shares worth $4.8K. The stake represents ﹤0.01% of the portfolio and ranks #1587 among its holdings.

14 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

Fortitude Family Office held 312 shares of AngioDynamics worth $4.8K as of Q3 2026.
AngioDynamics was a new Fortitude Family Office position in Q3 2026.
AngioDynamics made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1587 holding.
14 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.